ATE499114T1 - Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen - Google Patents

Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen

Info

Publication number
ATE499114T1
ATE499114T1 AT03764286T AT03764286T ATE499114T1 AT E499114 T1 ATE499114 T1 AT E499114T1 AT 03764286 T AT03764286 T AT 03764286T AT 03764286 T AT03764286 T AT 03764286T AT E499114 T1 ATE499114 T1 AT E499114T1
Authority
AT
Austria
Prior art keywords
erythropoiety
compositions containing
medicinal compositions
stabilized aqueous
aqueous medicinal
Prior art date
Application number
AT03764286T
Other languages
English (en)
Inventor
Andreja Vukmirovic
Tanja Rozman
Jelka Svetek
Alenka Paris
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE499114T1 publication Critical patent/ATE499114T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
AT03764286T 2002-07-17 2003-07-14 Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen ATE499114T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200178A SI21258A (sl) 2002-07-17 2002-07-17 Stabilni farmacevtski pripravek, ki vsebuje eritropoietin in poloksamerni poliol
PCT/SI2003/000023 WO2004006958A1 (en) 2002-07-17 2003-07-14 Stable pharmaceutical composition comprising erythropoietin

Publications (1)

Publication Number Publication Date
ATE499114T1 true ATE499114T1 (de) 2011-03-15

Family

ID=30113492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03764286T ATE499114T1 (de) 2002-07-17 2003-07-14 Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen

Country Status (11)

Country Link
US (1) US7534870B2 (de)
EP (1) EP1524998B1 (de)
JP (1) JP2005535673A (de)
CN (1) CN1668333A (de)
AT (1) ATE499114T1 (de)
AU (1) AU2003251284B2 (de)
CA (1) CA2492485A1 (de)
DE (1) DE60336142D1 (de)
MX (1) MXPA05000662A (de)
SI (1) SI21258A (de)
WO (1) WO2004006958A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004244920B2 (en) * 2003-06-10 2009-07-23 Lg Chem, Ltd. Stable, aqueous solution of human erythropoietin, not containing serum albumin
CN100342909C (zh) * 2005-05-11 2007-10-17 北京双鹭药业股份有限公司 一种胸腺素α1的水溶液制剂、其制备方法及应用
US8546329B2 (en) * 2006-03-22 2013-10-01 Chugai Seiyaku Kabushiki Kaisha Erythropoietin solution preparation
JP2011116752A (ja) * 2009-10-29 2011-06-16 Jcr Pharmaceuticals Co Ltd エリスロポエチン含有水性液剤
RU2682720C2 (ru) * 2010-01-19 2019-03-21 Ханми Сайенс Ко., Лтд. Жидкие составы для конъюгата эритропоэтина длительного действия
CN105431378A (zh) * 2014-06-25 2016-03-23 生物辐射实验室股份有限公司 纳米粒子-抗体偶联物的纯化

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6191131A (ja) 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
EP0803255A4 (de) * 1994-06-03 1999-06-30 Tsumura & Co Arzneimittel
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
AU2001236005A1 (en) * 2000-02-29 2001-09-12 Chugai Seiyaku Kabushiki Kaisha Preparations stabilized over long time
WO2001087329A1 (en) * 2000-05-15 2001-11-22 F. Hoffmann-La Roche Ag Liquid pharmaceutical composition containing an erythropoietin derivate
EP1351696A4 (de) * 2000-06-26 2004-04-14 Rxkinetix Inc Zusammensetzung für die zubereitung eines hematopoietischen wachstumsfaktors

Also Published As

Publication number Publication date
WO2004006958A1 (en) 2004-01-22
CA2492485A1 (en) 2004-01-22
SI21258A (sl) 2004-02-29
AU2003251284B2 (en) 2007-08-02
JP2005535673A (ja) 2005-11-24
AU2003251284A1 (en) 2004-02-02
EP1524998B1 (de) 2011-02-23
CN1668333A (zh) 2005-09-14
MXPA05000662A (es) 2005-08-19
US7534870B2 (en) 2009-05-19
EP1524998A1 (de) 2005-04-27
DE60336142D1 (de) 2011-04-07
US20050202091A1 (en) 2005-09-15
WO2004006958A8 (en) 2005-01-13
AU2003251284B9 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
DK1086706T3 (da) Stabiliserede sammensætninger indeholdende nootropiske lægemidler
SV2003001106A (es) Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco ref.pc11846
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
UY27320A1 (es) Nuevas composiciones farmacéuticas
BR0307541A (pt) Composição para cuidado pessoal e composição cosmética
HN2002000300A (es) Nuevos derivados de piperazina
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
IL160051A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
BR0212386A (pt) Composto, formulação farmacêutica, e, uso de um composto
ATE331497T1 (de) Zweiphasen kosmetische zusammensetzung
ES2180274T3 (es) Disoluciones nasales.
EE200300476A (et) 4-tsüanotrifluoro-3-(4-fluorofenüülsulfonüül)-2-hüdroksü-2-metüülpropiono-m-toluidii di ja PVP-d sisaldav tahke farmatseutiline kompositsioon
BR0111678A (pt) Composições medicinais contendo derivados de propenona
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
ATE499114T1 (de) Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen
BRPI0403461A (pt) composições estabilizadas contendo um agente ativo lábil ao oxigênio
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
ATE318575T1 (de) Orale zubereitung chlorhexidin und maltitol oder erythritol oder deren mischung enthaltend
BR0307696A (pt) Composição desodorante ou antitranspirante
ATE301463T1 (de) Pharmazeutische zusammensetzungen enthaltend 17alpha-furanylester von 17beta-carbothioat androstanderivaten und einen muskarinrezeptorantagonist
BR0206922A (pt) Compostos orgânicos
MXPA05000661A (es) Composicion farmaceutica estable que comprende eritropoyetina.
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
PT1250125E (pt) Composicoes farmaceuticas contendo terbinafina
BR9915835A (pt) Composição farmacêutica, e, processo para a preparação de uma composição

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties